METHOD OF TREATING TUBERCULOUS SPASTIC MICROCYSTIS Russian patent published in 2014 - IPC A61M25/01 A61H39/02 A61N5/67 

FIELD: medicine.

SUBSTANCE: treating tuberculous spastic microcystis with underlying anti-tuberculosis chemotherapy requires peridural anaesthesia 5-7 days long. That is combined with the exposure to a laser light at a wave length of 632 nm of power 12 mW covering a biologically active point of the urinary bladder on a hand. The 4-minute exposure is daily for 5-7 days.

EFFECT: higher clinical effectiveness by the fast reduction of pain syndrome, higher urinary bladder capacity, avoiding the need of surgical intervention and disability.

1 tbl, 2 ex